Alliance Pharma, a U.S. provider of small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, has purchased Drug Development Solutions (DDS), a UK-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital Partners, a global healthcare private equity firm, and KKR & Co. Inc., a global investment firm, are equal shareholders in the combined company. This transaction expands bioanalytical, analy...